Merck profit nearly halves on Organon spin off

(Reuters) – Merck & Co Inc on Thursday reported a 49% fall in second-quarter profit after it spun off its women’s health and biosimilar assets into Organon in June.

(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)